目的:深入剖析吕文良教授治疗非酒精性脂肪性肝病(NAFLD)的临床用药规律。方法:基于真实世界研究数据收集和整理吕文良教授于2017年1月1日至2023年5月23日在中国中医科学院广安门医院门诊治疗NAFLD的处方1 383份,采用Excel建立规范化、标准化临床资料数据库,借助SPSS Statistics 20.0、SPSS Modeler 18.0软件进行高频药物的关联规则分析、聚类分析。结果:共纳入处方1 383首,涉及药物355味,其中频次排名前10的药物分别是:白芍、柴胡、茵陈、黄芪、荷叶、白术、茯苓、当归、甘草、垂盆草;药性多偏温、平、寒,药味以苦、甘、辛为主; 主入肝、肺、胃、脾经;共产生“香附→当归、川楝子→香附、当归→香附、黄连→泽泻、苍术→泽泻”等12条药物配伍,聚类分析共得到“垂盆草、金钱草、茵陈、荷叶、鸡内金、姜黄、山药、薏苡仁”等3个聚类方。结论:吕教授认为“湿、热、瘀、痰、虚、郁”是NAFLD主要病理因素,以健脾疏肝、清利湿热活血为主要治则,在治法上强调攻补兼施、寒温并用、甘苦合用、气血同调、随症加减,讲求以平为期、以和为要。
Abstract
Objective: Analyzing Clinical Medication Practices of Professor Lv Wenliang for Treating Non-Alcoholic Fatty Liver Disease (NAFLD).Methods: Based on real-world medical data, we collected and collated 1,383 prescriptions of Professor Lv Wenliang for the treatment of NAFLD in the outpatient clinic of Guang'anmen Hospital of the China Academy of Traditional Chinese Medicine (CATCM) from 1 January 2017 to 23 May 2023 and used Excel to establish a normalized and standardized database for the clinical information, and then with the help of SPSS Statistics 20.0 and SPSS Modeler 18.0 software for association rule analysis and cluster analysis of HF drugs.Results: A total of 1,383 prescriptions were included, involving 355 flavors of drugs, of which the top 10 drugs in terms of frequency were: Paeonia lactiflora, Radix Bupleurum Chinense, Herba Leonurus, Radix Astragali, Lotus leaf, Rhizoma Atractylodis Macrocephalae, Poria cocos, Radix Angelicae Sinensis, Glycyrrhiza Uralensis, and Herba Taraxacum Chinense, which are mostly warm, calm, and cold in nature, with bitter, sweet, and pungent flavors; they are mainly found in the meridians of the liver, lungs, stomach, and spleen. There were 12 drug combinations such as "Xiang Fu → Angelica sinensis, Neem Ziziphi → Xiang Fu, Huang Lian → Ze Xie, Cang Zhu → Ze Xie," and 3 cluster formulas such as "Tarragon grass, Qian Cao, Yin Chen, Lotus Leaf, Chicken Nei Jin, turmeric, Chinese yam, and Semen Coix lacryma" were obtained from the cluster analysis.Conclusion: Professor Lv believed that "dampness, heat, stasis, phlegm, deficiency, and depression" are the main pathological factors of NAFLD, and that the main treatment principle is to strengthen the spleen and dredge the liver, clear dampness, heat, and activate blood, and to emphasize the combination of attacking and tonifying, combining cold and warmth, combining sweetness and bitterness, regulating qi and blood, and adding and subtracting according to the symptom, and emphasizing the principle of peacefulness and the importance of harmony.
关键词
NAFLD /
非酒精性脂肪性肝病 /
岐黄学者经验 /
中医用药规律
{{custom_keyword}} /
Key words
Nonalcoholic fatty liver disease /
the experience of Qichuang scholar /
rule of medicine in Chinese medicine
{{custom_keyword}} /
中图分类号:
R256.4
R575.5
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Riazi k,Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analy-sis[J]. Lancet Gastroenterol Hepatol, 2022, 7(9): 851-861.
[2] Powell EE,Wong VW,Rinella M. Non-alcoholic fatty liver disea-se[J].Lancet(London,England),2021,397(10290):2212-2224.
[3] 陈慧慧, 王乾皓, 陈润花,等. 中药代茶饮干预非酒精性脂肪性肝病湿热蕴结证的临床研究[J]. 中华中医药杂志, 2023, 38(2): 902-905.
[4] 冯健茹, 许光远. 茵陈蒿汤合四逆散治疗非酒精性脂肪肝伴高同型半胱氨酸血症临床观察[J]. 中国实验方剂学杂志, 2019, 25(16): 61-66.
[5] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版) [J]. 临床肝胆病杂志, 2018, 34(5): 947-957.
[6] 唐允婷, 陈宇彬, 吴小文, 等. 非酒精性脂肪肝与单纯性肥胖中医治疗方剂用药规律对比分析[J]. 浙江中医药大学学报, 2023, 47(7): 804-812.
[7] 陈思童, 吕文良. 吕文良论治非酒精性脂肪性肝病经验[J]. 辽宁中医杂志, 2022, 49(7): 31-34.
[8] 强睿, 李彦波, 冯佳琪, 等. 吕文良谈“和其不和”治疗肝积[J]. 中西医结合肝病杂志, 2022, 32(4): 364-366.
[9] 钟顾欣, 张平. 不寐因机证治与常用药对分析[J]. 辽宁中医药大学学报, 2021, 23(11): 197-200.
[10] 党伟利, 冯刚, 李华伟, 等. 黄芪白术汤辨治小儿脾虚型便秘的临床疗效及其机制研究[J]. 世界中医药, 2019, 14(6): 1471-1475.
[11] 黄桢, 魏毅, 王卓, 等. 白芍总苷对NAFLD大鼠炎症通路中TLR4和JNK蛋白表达的影响[J]. 湖南师范大学学报(医学版), 2018, 15(2): 23-27.
[12] 强睿, 王衍鸿, 武庆娟, 等. 基于“同气相求”理论探讨山楂治疗原发性肝癌[J]. 云南中医学院学报, 2020, 43(6): 26-31.
[13] Li T, Wang H, Dong S, et al. Protective effects of maslinic acid on high fat diet-induced liver injury in mice[J]. Life Sci, 2022, 301:120634.
[14] Li C, Chen Y, Yuan X, et al. Vitexin ameliorates chronic stress plub high fat diet-induced nonalcoholic fatty liver disease by inhibiting inflammation[J].Eur J Pharmacol,2020,882:173264.
[15] 赵建根, 李壮壮, 黄辉. 王乐匋教授寒温并用论治特色及验案分析[J]. 陕西中医药大学学报, 2022, 45(4): 50-53.
[16] 卫向龙, 许二平.《脾胃论》甘苦配伍法探析[J]. 时珍国医国药, 2010, 21(10): 2424.
[17] 高屿潆, 黄文忠, 何诗婷, 等. 从甘露饮窥探阴虚湿热证治之要[J]. 湖北中医药大学学报, 2022, 24(5): 57-60.
[18] 杨延泽, 邓毅, 杨秀娟, 等. 当归不同配伍对急性血瘀大鼠血液流变学、凝血功能及心、肺病理影响[J]. 中药药理与临床, 2018, 34(6):125-129.
[19] 陈卫衡, 赵岩. 从病证结合到证症结合,探讨突出疗效优势环节的诊疗模式[J]. 环球中医药, 2021, 14(5): 917-919.
[20] 蔡晓华. 海洋矿物药海螵蛸的研究进展与方向[J]. 中华中医药杂志, 2018, 33(9): 4013-4015.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
* 国家自然科学基金(No.82374332),北京市自然科学基金(No.7222295),中国中医科学院科技创新工程(No.CI2021A00801,CI2021A00802)
{{custom_fund}}